The bone marrow-cardiac axis: Role of endothelial progenitor cells in heart failure

European Journal of Cardio-thoracic Surgery

Volumn 39, Issue 3, 2011, Pages 368-374

  Maltais, Simon ^a   Perrault, Louis P ^a   Ly, Hung Q ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Bone marrow axis; Heart failure; Progenitor cells; Therapy

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PLACEBO; PRAVASTATIN; ROSUVASTATIN; STROMAL CELL DERIVED FACTOR 1;

BONE MARROW; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CELL REGENERATION; CORONARY ARTERY BYPASS SURGERY; ENDOTHELIAL PROGENITOR CELL; HEART FAILURE; HEART FUNCTION; HEART MUSCLE; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVIEW; STEM CELL MOBILIZATION; TISSUE REGENERATION;

EID: 79951512405     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2010.04.022     Document Type: Review

References (78)

1. Hunt S.A. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 2005, 46:e1-82.
2. Howlett J.G., McKelvie R.S., Arnold J.M., Costigan J., Dorian P., Ducharme A., Estrella-Holder E., Ezekowitz J.A., Giannetti N., Haddad H., Heckman G.A., Herd A.M., Isaac D., Jong P., Kouz S., Liu P., Mann E., Moe G.W., Tsuyuki R.T., Ross H.J., White M. Canadian Cardiovascular Society Consensus Conference guidelines on heart failure, update 2009: diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials. Can J Cardiol 2009, 25:85-105.
3. Schocken D.D., Benjamin E.J., Fonarow G.C., Krumholz H.M., Levy D., Mensah G.A., Narula J., Shor E.S., Young J.B., Hong Y. Prevention of heart failure: a scientific statement from the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation 2008, 117:2544-2565.
4. Rosamond W., Flegal K., Friday G., Furie K., Go A., Greenlund K., Haase N., Ho M., Howard V., Kissela B., Kittner S., Lloyd-Jones D., McDermott M., Meigs J., Moy C., Nichol G., O'Donnell C.J., Roger V., Rumsfeld J., Sorlie P., Steinberger J., Thom T., Wasserthiel-Smoller S., Hong Y. Heart disease and stroke statistics-2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007, 115:e69-e171.
5. Pfeffer M.A., Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 1990, 81:1161-1172.
6. Sutton M.G., Sharpe N. Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation 2000, 101:2981-2988.
7. Braunwald E. Biomarkers in heart failure. N Engl J Med 2008, 358:2148-2159.
8. Boudina S., Bugger H., Sena S., O'Neill B.T., Zaha V.G., Ilkun O., Wright J.J., Mazumder P.K., Palfreyman E., Tidwell T.J., Theobald H., Khalimonchuk O., Wayment B., Sheng X., Rodnick K.J., Centini R., Chen D., Litwin S.E., Weimer B.E., Abel E.D. Contribution of impaired myocardial insulin signaling to mitochondrial dysfunction and oxidative stress in the heart. Circulation 2009, 119:1272-1283.
9. McMurray J., Pfeffer M.A. New therapeutic options in congestive heart failure: Part II. Circulation 2002, 105:2223-2228.
10. McMurray J., Pfeffer M.A. New therapeutic options in congestive heart failure: Part I. Circulation 2002, 105:2099-2106.
11. Kucia M., Dawn B., Hunt G., Guo Y., Wysoczynski M., Majka M., Ratajczak J., Rezzoug F., Ildstad S.T., Bolli R., Ratajczak M.Z. Cells expressing early cardiac markers reside in the bone marrow and are mobilized into the peripheral blood after myocardial infarction. Circ Res 2004, 95:1191-1199.
12. Valgimigli M., Rigolin G.M., Fucili A., Porta M.D., Soukhomovskaia O., Malagutti P., Bugli A.M., Bragotti L.Z., Francolini G., Mauro E., Castoldi G., Ferrari R. CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure. Circulation 2004, 110:1209-1212.
13. Nolan D.J., Ciarrocchi A., Mellick A.S., Jaggi J.S., Bambino K., Gupta S., Heikamp E., McDevitt M.R., Scheinberg D.A., Benezra R., Mittal V. Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization. Genes Dev 2007, 21:1546-1558.
14. Rafii S., Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 2003, 9:702-712.
15. Hristov M., Erl W., Weber P.C. Endothelial progenitor cells: isolation and characterization. Trends Cardiovasc Med 2003, 13:201-206.
16. Quirici N., Soligo D., Caneva L., Servida F., Bossolasco P., Deliliers G.L. Differentiation and expansion of endothelial cells from human bone marrow CD133(+) cells. Br J Haematol 2001, 115:186-194.
17. Reyes M., Dudek A., Jahagirdar B., Koodie L., Marker P.H., Verfaillie C.M. Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest 2002, 109:337-346.
18. Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., Witzenbichler B., Schatteman G., Isner J.M. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964-967.
19. Shantsila E., Watson T., Lip G.Y. Endothelial progenitor cells in cardiovascular disorders. J Am Coll Cardiol 2007, 49:741-752.
20. Hill J.M., Zalos G., Halcox J.P., Schenke W.H., Waclawiw M.A., Quyyumi A.A., Finkel T. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003, 348:593-600.
21. Werner N., Kosiol S., Schiegl T., Ahlers P., Walenta K., Link A., Bohm M., Nickenig G. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005, 353:999-1007.
22. Fritzenwanger M., Lorenz F., Jung C., Fabris M., Thude H., Barz D., Figulla H.R. Differential number of CD34+, CD133+ and CD34+/CD133+ cells in peripheral blood of patients with congestive heart failure. Eur J Med Res 2009, 14:113-117.
23. Dimmeler S., Zeiher A.M. Vascular repair by circulating endothelial progenitor cells: the missing link in atherosclerosis?. J Mol Med 2004, 82:671-677.
24. Heeschen C., Lehmann R., Honold J., Assmus B., Aicher A., Walter D.H., Martin H., Zeiher A.M., Dimmeler S. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 2004, 109:1615-1622.
25. Kissel C.K., Lehmann R., Assmus B., Aicher A., Honold J., Fischer-Rasokat U., Heeschen C., Spyridopoulos I., Dimmeler S., Zeiher A.M. Selective functional exhaustion of hematopoietic progenitor cells in the bone marrow of patients with postinfarction heart failure. J Am Coll Cardiol 2007, 49:2341-2349.
26. Ballard V.L., Edelberg J.M. Stem cells and the regeneration of the aging cardiovascular system. Circ Res 2007, 100:1116-1127.
27. Endemann D.H., Schiffrin E.L. Endothelial dysfunction. J Am Soc Nephrol 2004, 15:1983-1992.
28. Rochefort G.Y. Circulating progenitor cells in coronary heart disease. Heart 2008, 94:793-794. author reply 794.
29. Eizawa T., Ikeda U., Murakami Y., Matsui K., Yoshioka T., Takahashi M., Muroi K., Shimada K. Decrease in circulating endothelial progenitor cells in patients with stable coronary artery disease. Heart 2004, 90:685-686.
30. Xiao Q., Kiechl S., Patel S., Oberhollenzer F., Weger S., Mayr A., Metzler B., Reindl M., Hu Y., Willeit J., Xu Q. Endothelial progenitor cells, cardiovascular risk factors, cytokine levels and atherosclerosis-results from a large population-based study. PLoS One 2007, 2:e975.
31. Testa M., Yeh M., Lee P., Fanelli R., Loperfido F., Berman J.W., LeJemtel T.H. Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension. J Am Coll Cardiol 1996, 28:964-971.
32. Karra R., Vemullapalli S., Dong C., Herderick E.E., Song X., Slosek K., Nevins J.R., West M., Goldschmidt-Clermont P.J., Seo D. Molecular evidence for arterial repair in atherosclerosis. Proc Natl Acad Sci U S A 2005, 102:16789-16794.
33. Fujiyama S., Amano K., Uehira K., Yoshida M., Nishiwaki Y., Nozawa Y., Jin D., Takai S., Miyazaki M., Egashira K., Imada T., Iwasaka T., Matsubara H. Bone marrow monocyte lineage cells adhere on injured endothelium in a monocyte chemoattractant protein-1-dependent manner and accelerate reendothelialization as endothelial progenitor cells. Circ Res 2003, 93:980-989.
34. Lapidot T., Petit I. Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp Hematol 2002, 30:973-981.
35. Tilling L., Chowienczyk P., Clapp B. Progenitors in motion: mechanisms of mobilization of endothelial progenitor cells. Br J Clin Pharmacol 2009, 68:484-492.
36. Tashiro K., Tada H., Heilker R., Shirozu M., Nakano T., Honjo T. Signal sequence trap: a cloning strategy for secreted proteins and type I membrane proteins. Science 1993, 261:600-603.
37. Levesque J.P., Hendy J., Takamatsu Y., Simmons P.J., Bendall L.J. Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. J Clin Invest 2003, 111:187-196.
38. De Falco E., Porcelli D., Torella A.R., Straino S., Iachininoto M.G., Orlandi A., Truffa S., Biglioli P., Napolitano M., Capogrossi M.C., Pesce M. SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells. Blood 2004, 104:3472-3482.
39. Hattori K., Heissig B., Tashiro K., Honjo T., Tateno M., Shieh J.H., Hackett N.R., Quitoriano M.S., Crystal R.G., Rafii S., Moore M.A. Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells. Blood 2001, 97:3354-3360.
40. Wright D.E., Bowman E.P., Wagers A.J., Butcher E.C., Weissman I.L. Hematopoietic stem cells are uniquely selective in their migratory response to chemokines. J Exp Med 2002, 195:1145-1154.
41. Peichev M., Naiyer A.J., Pereira D., Zhu Z., Lane W.J., Williams M., Oz M.C., Hicklin D.J., Witte L., Moore M.A., Rafii S. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 2000, 95:952-958.
42. Ceradini D.J., Kulkarni A.R., Callaghan M.J., Tepper O.M., Bastidas N., Kleinman M.E., Capla J.M., Galiano R.D., Levine J.P., Gurtner G.C. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 2004, 10:858-864.
43. Heissig B., Hattori K., Dias S., Friedrich M., Ferris B., Hackett N.R., Crystal R.G., Besmer P., Lyden D., Moore M.A., Werb Z., Rafii S. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 2002, 109:625-637.
44. Petit I., Jin D., Rafii S. The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis. Trends Immunol 2007, 28:299-307.
45. Massa M., Rosti V., Ferrario M., Campanelli R., Ramajoli I., Rosso R., De Ferrari G.M., Ferlini M., Goffredo L., Bertoletti A., Klersy C., Pecci A., Moratti R., Tavazzi L. Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. Blood 2005, 105:199-206.
46. Isner J.M. Tissue responses to ischemia: local and remote responses for preserving perfusion of ischemic muscle. J Clin Invest 2000, 106:615-619.
47. Tepper O.M., Capla J.M., Galiano R.D., Ceradini D.J., Callaghan M.J., Kleinman M.E., Gurtner G.C. Adult vasculogenesis occurs through in situ recruitment, proliferation, and tubulization of circulating bone marrow-derived cells. Blood 2005, 105:1068-1077.
48. Minchenko A., Salceda S., Bauer T., Caro J. Hypoxia regulatory elements of the human vascular endothelial growth factor gene. Cell Mol Biol Res 1994, 40:35-39.
49. Brogi E., Schatteman G., Wu T., Kim E.A., Varticovski L., Keyt B., Isner J.M. Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression. J Clin Invest 1996, 97:469-476.
50. Laterveer L., Zijlmans J.M., Lindley I.J., Hamilton M.S., Willemze R., Fibbe W.E. Improved survival of lethally irradiated recipient mice transplanted with circulating progenitor cells mobilized by IL-8 after pretreatment with stem cell factor. Exp Hematol 1996, 24:1387-1393.
51. King A.G., Horowitz D., Dillon S.B., Levin R., Farese A.M., MacVittie T.J., Pelus L.M. Rapid mobilization of murine hematopoietic stem cells with enhanced engraftment properties and evaluation of hematopoietic progenitor cell mobilization in Rhesus monkeys by a single injection of SB-251353, a specific truncated form of the human CXC chemokine GRObeta. Blood 2001, 97:1534-1542.
52. Dimmeler S., Burchfield J., Zeiher A.M. Cell-based therapy of myocardial infarction. Arterioscler Thromb Vasc Biol 2008, 28:208-216.
53. Losordo D.W., Dimmeler S. Therapeutic angiogenesis and vasculogenesis for ischemic disease. Part II. Cell-based therapies. Circulation 2004, 109:2692-2697.
54. Kocher A.A., Schuster M.D., Szabolcs M.J., Takuma S., Burkhoff D., Wang J., Homma S., Edwards N.M., Itescu S. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001, 7:430-436.
55. Gill M., Dias S., Hattori K., Rivera M.L., Hicklin D., Witte L., Girardi L., Yurt R., Himel H., Rafii S. Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells. Circ Res 2001, 88:167-174.
56. Kalka C., Masuda H., Takahashi T., Kalka-Moll W.M., Silver M., Kearney M., Li T., Isner J.M., Asahara T. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A 2000, 97:3422-3427.
57. Agnoletti L., Curello S., Bachetti T., Malacarne F., Gaia G., Comini L., Volterrani M., Bonetti P., Parrinello G., Cadei M., Grigolato P.G., Ferrari R. Serum from patients with severe heart failure downregulates eNOS and is proapoptotic: role of tumor necrosis factor-alpha. Circulation 1999, 100:1983-1991.
58. Dimmeler S., Aicher A., Vasa M., Mildner-Rihm C., Adler K., Tiemann M., Rutten H., Fichtlscherer S., Martin H., Zeiher A.M. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest 2001, 108:391-397.
59. Laufs U., Werner N., Link A., Endres M., Wassmann S., Jurgens K., Miche E., Bohm M., Nickenig G. Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. Circulation 2004, 109:220-226.
60. Rupp S., Badorff C., Koyanagi M., Urbich C., Fichtlscherer S., Aicher A., Zeiher A.M., Dimmeler S. Statin therapy in patients with coronary artery disease improves the impaired endothelial progenitor cell differentiation into cardiomyogenic cells. Basic Res Cardiol 2004, 99:61-68.
61. Metra M., Zaca V., Nodari S., Cas L.D., Maggioni A.P. [The CORONA study]. G Ital Cardiol (Rome) 2008, 9:229-233.
62. Yao E.H., Yu Y., Fukuda N. Oxidative stress on progenitor and stem cells in cardiovascular diseases. Curr Pharm Biotechnol 2006, 7:101-108.
63. Fuchs E., Segre J.A. Stem cells: a new lease on life. Cell 2000, 100:143-155.
64. Orlic D., Kajstura J., Chimenti S., Bodine D.M., Leri A., Anversa P. Transplanted adult bone marrow cells repair myocardial infarcts in mice. Ann N Y Acad Sci 2001, 938:221-229. discussion 229-30.
65. Orlic D., Kajstura J., Chimenti S., Limana F., Jakoniuk I., Quaini F., Nadal-Ginard B., Bodine D.M., Leri A., Anversa P. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci U S A 2001, 98:10344-10349.
66. Asahara T., Masuda H., Takahashi T., Kalka C., Pastore C., Silver M., Kearne M., Magner M., Isner J.M. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999, 85:221-228.
67. Mouquet F., Pfister O., Jain M., Oikonomopoulos A., Ngoy S., Summer R., Fine A., Liao R. Restoration of cardiac progenitor cells after myocardial infarction by self-proliferation and selective homing of bone marrow-derived stem cells. Circ Res 2005, 97:1090-1092.
68. Wang Y., Haider H.K., Ahmad N., Xu M., Ge R., Ashraf M. Combining pharmacological mobilization with intramyocardial delivery of bone marrow cells over-expressing VEGF is more effective for cardiac repair. J Mol Cell Cardiol 2006, 40:736-745.
69. Rosenzweig A. Cardiac cell therapy-mixed results from mixed cells. N Engl J Med 2006, 355:1274-1277.
70. Assmus B., Schachinger V., Teupe C., Britten M., Lehmann R., Dobert N., Grunwald F., Aicher A., Urbich C., Martin H., Hoelzer D., Dimmeler S., Zeiher A.M. Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation 2002, 106:3009-3017.
71. Suzuki G., Iyer V., Cimato T., Canty J.M. Pravastatin improves function in hibernating myocardium by mobilizing CD133+ and cKit+ bone marrow progenitor cells and promoting myocytes to reenter the growth phase of the cardiac cell cycle. Circ Res 2009, 104:255-264. 210 p. following 264.
72. Llevadot J., Murasawa S., Kureishi Y., Uchida S., Masuda H., Kawamoto A., Walsh K., Isner J.M., Asahara T. HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells. J Clin Invest 2001, 108:399-405.
73. Vasa M., Fichtlscherer S., Adler K., Aicher A., Martin H., Zeiher A.M., Dimmeler S. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 2001, 103:2885-2890.
74. Werner N., Priller J., Laufs U., Endres M., Bohm M., Dirnagl U., Nickenig G. Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation: effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition. Arterioscler Thromb Vasc Biol 2002, 22:1567-1572.
75. Zhang Q., Liu L., Zheng X.Y. Protective roles of HDL, apoA-I and mimetic peptide on endothelial function: through endothelial cells and endothelial progenitor cells. Int J Cardiol 2009, 133:286-292.
76. Scheubel R.J., Zorn H., Silber R.E., Kuss O., Morawietz H., Holtz J., Simm A. Age-dependent depression in circulating endothelial progenitor cells in patients undergoing coronary artery bypass grafting. J Am Coll Cardiol 2003, 42:2073-2080.
77. Roberts N., Xiao Q., Weir G., Xu Q., Jahangiri M. Endothelial progenitor cells are mobilized after cardiac surgery. Ann Thorac Surg 2007, 83:598-605.
78. Ruel M., Suuronen E.J., Song J., Kapila V., Gunning D., Waghray G., Rubens F.D., Mesana T.G. Effects of off-pump versus on-pump coronary artery bypass grafting on function and viability of circulating endothelial progenitor cells. J Thorac Cardiovasc Surg 2005, 130:633-639.